NCT06623071View on ClinicalTrials.gov

Accupower ® HBV Performance Evaluation Quant Kit Bioneer Existation FA 96/384

RecruitingOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

March 24, 2025

Study Completion Date

May 31, 2025

Conditions
Hepatitis B
Trial Locations (2)

75000

RECRUITING

Cerballiance Chemin vert, France

95000

NOT_YET_RECRUITING

Cerba Xpert, Frépillon

Sponsors

Collaborators (1)

Bioneer Corporation
All Listed Sponsors
collaborator

Bioneer Corporation

UNKNOWN

lead

CerbaXpert

OTHER

NCT06623071 - Accupower ® HBV Performance Evaluation Quant Kit Bioneer Existation FA 96/384 | Biotech Hunter | Biotech Hunter